Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Futures Intelligence

Insider Talk: Christopher Jones of Diamond Peak Capital argues that investors do better if they don't lump together strategies and time frames.

Thursday, February 24, 2011

Pigeonholing Managers Can Harm Investors

Christopher Jones, founder and principal of Diamond Peak Capital, is a thoughtful observer of the industry as well as a working commodity trading advisor. We featured him in Opalesque Futures Intelligence two years ago, when he talked about transparency and managed accounts-topics that get a lot of attention nowadays.

In October 2008 he and Steve Sapourn started Northstar, a long/short equity quantitative trading program. The talk below is based on his experience as a stock market trader who is also a CTA.


 "Some investors assume short-term trading is the same as high-frequency trading, but we are not high-frequency traders."

Opalesque Futures Intelligence: Have investors become more interested in managed futures?
Christopher Jones: It's a process, but over time the broader universe of investors is finally considering commodity trading advisors as a unique asset class with specific benefits. This is gratifying because the industry has been proving, for many years and through sound research, that it is low- or negatively-correlated to other asset classes including certain hedge fund strategies. The top trend followers who have track records going back decades have clearly established that managed futures is a viable asset class. Part of investors' acceptance of managed futures, we owe to trend followers. That's the glass half-full perspective.

OFI: What's the glass half-empty story?
CJ: Simultaneously, the managed futures space has perhaps become overly identified with trend-following CTAs and their risk-reward profiles. So there is a pigeonholing that sometimes occurs where other managers in the space are concerned. Long-term trend followers tend to have volatile returns and occasional large drawdowns, 30% or 50% for example. Having learnt that, some investors erroneously assume that any program using futures as an instrument is subject to big drawdowns. Investors generally associate CTAs and futures traders with greater volatility and less consistent returns when compared to hedge fund strategies. Given these misconceptions, investors don't particularly understand the diversification they can get through CTAs. This potentially hurts investor results-they could get better returns for their risk by creating a stable of managers with distinct strategies, including all asset classes.

OFI: What effect does this have on managed futures?
CJ: It makes it more challenging for CTAs generally to raise money. A manager can have a unique approach that happens to use futures as an instrument and achieves low-volatility returns, but some investors won't consider it because of these misperceptions and the over-association with volatility and high risk. Maybe their mandate specifies that the manager can't trade in futures, which is worth reconsidering because futures comprise a wide variety of sectors and markets that can be used to pursue numerous strategies, many of them having little in common with trend following.

OFI: What do you suggest?
CJ: 'Managed futures', 'CTA', 'futures trader', doesn't tell an investor much about markets, strategy or time frame. One has to drill down into what the manager is doing. We're simply suggesting that investors take their research efforts case by case and avoid categorically ruling out managers who they know little about. There's a highly diverse field of strategies within managed futures-it's time for perspective to catch up with the universe.

OFI: Aren't people impressed by the high long-term annualized returns of certain trend followers?
CJ: I think it is fair to say that only a small percentage of investors are able to withstand large drawdowns, even if the long-term record is great.

OFI: What is your strategy?
CJ: We trade equity index futures using a systematic approach based on mean reversion. You could think of it as a long/short equity investment since we focus strictly on the stock market, however, the program is more directional and less hedged. We are very much a multi-category manager, but since we use futures to implement the strategy, we usually get classed as a CTA, which means we are rejected if an investor does not want CTAs. As a result, and to avoid being pigeonholed, we also offer the program in securities.

OFI: How does your strategy correlate with long term trend followers?
CJ: We're not correlated. For instance, 2009 was one of the most difficult years for quantitative CTAs in a long time, but we earned 32%! Our correlation to the CTA universe as a whole is about 20%, yet we're apt to be regarded as similar to other CTAs.

OFI: What's the time frame of your strategy?
CJ: The program is a short-term trading strategy, best described as a swing trading approach. Some investors assume short-term trading is the same as high-frequency trading, but we are not high-frequency traders. High-frequency trading relies much more on technology, speed and execution than we do. Our average holding period is about three days. There can be an intra-day element - holding for a few hours - but it is a small percentage of the portfolio.

OFI: Does short-term trading have an advantage?
CJ: Time frame is a key issue. While long-term investing may be right for many people, we have found that staying within a shorter horizon enables us to produce a good return at the right risk price. Generally speaking, the longer you hold an investment, the greater the peak-to-trough drawdown you need to be able to withstand over time. For us, the shorter time frame means greater control of risk. It helps us keep drawdowns palatable, while maintaining a higher return than the market.

OFI: How does the market look?
CJ: Short term equity trading strategies struggled in 2010 because of erratic movements in stocks. This year so far equity markets seem to be on a more solid footing. That has helped us. Here again, we prove to be uncorrelated, as quantitative CTAs generally had a good 2010. Ultimately this works out fine because according to some of the most sophisticated investors we know, it's all about correlation.



 
This article was published in Opalesque Futures Intelligence.
Opalesque Futures Intelligence
Opalesque Futures Intelligence
Opalesque Futures Intelligence
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its